EZZ Life Science Holdings Ltd
EZZ
Company Profile
Business description
EZZ Life Science Holdings Ltd is a genomic life science company with a mission to improve quality of life and human health. EZZ has a focus on genomic research and development to address four key human health challenges: genetic longevity, human papillomavirus (HPV), helicobacter pylori, and weight management. The company is engaged in formulation, production, marketing and sale of the EZZ branded health and wellbeing products to retailers and consumers domestically and internationally, and wholesale distribution of the EAORON branded skin care products to retailers in Australia and New Zealand.
Contact
55-59 Parramatta Road
Shop 1
LidcombeNSW2141
AUST: +61 291602305
Sector
Healthcare
Stock type
Defensive
Industry
Biotechnology
Fiscal Year End
30 June 2026
Employees
Stocks News & Analysis
stocks
Will undervalued ASX share show progress in results?
Investors will get to see if the new strategy and capital management framework are working.
stocks
10 best US dividend aristocrats to buy now for 2026
These undervalued stocks with economic moats have increased their dividends for 25 consecutive years or more.
stocks
What to expect from the January Fed meeting
Central bankers are likely to hold interest rates steady, but Wall Street is focused on life after Powell.
Morningstar Investment Ideas
Markets
Index | Last price | Change | % Change |
|---|---|---|---|
| All Ordinaries | 9,299.80 | 1.50 | -0.02% |
| CAC 40 | 8,166.02 | 34.87 | 0.43% |
| DAX 40 | 24,953.34 | 20.26 | 0.08% |
| Dow JONES (US) | 49,055.99 | 356.41 | -0.72% |
| FTSE 100 | 10,222.41 | 73.56 | 0.72% |
| HKSE | 27,126.95 | 361.43 | 1.35% |
| NASDAQ | 23,700.33 | 98.98 | 0.42% |
| Nikkei 225 | 53,333.54 | 448.29 | 0.85% |
| NZX 50 Index | 13,493.71 | 17.17 | -0.13% |
| S&P 500 | 6,962.46 | 12.23 | 0.18% |
| S&P/ASX 200 | 8,975.10 | 0.80 | 0.01% |
| SSE Composite Index | 4,139.90 | 7.30 | 0.18% |